Literature DB >> 29177990

Atomoxetine-induced hyperadrenergic postural tachycardia syndrome: a case report.

Soken Go1, Naoko Saito2, Shinji Suzuki2, Tatsuro Hatsushika2, Koko Kato2, Akiko Kasuga2, Yasuyo Kashiwagi2, Hisashi Kawashima2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29177990     DOI: 10.1007/s10286-017-0486-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  5 in total

1.  Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance.

Authors:  Christoph Schroeder; Jens Tank; Michael Boschmann; Andre Diedrich; Arya M Sharma; Italo Biaggioni; Friedrich C Luft; Jens Jordan
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

2.  Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency.

Authors:  J R Shannon; N L Flattem; J Jordan; G Jacob; B K Black; I Biaggioni; R D Blakely; D Robertson
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

3.  Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome.

Authors:  Elisabeth Lambert; Nina Eikelis; Murray Esler; Tye Dawood; Markus Schlaich; Richard Bayles; Flora Socratous; Alex Agrotis; Garry Jennings; Gavin Lambert; Gautam Vaddadi
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-04-30

4.  Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome.

Authors:  Elizabeth A Green; Vidya Raj; Cyndya A Shibao; Italo Biaggioni; Bonnie K Black; William D Dupont; David Robertson; Satish R Raj
Journal:  J Am Heart Assoc       Date:  2013-09-03       Impact factor: 5.501

5.  Risk factors for postural tachycardia syndrome in children and adolescents.

Authors:  Jing Lin; Zhenhui Han; Xueying Li; Todd Ochs; Juan Zhao; Xi Zhang; Jinyan Yang; Ping Liu; Zhenyu Xiong; Yong Gai; Chaoshu Tang; Junbao Du; Hongfang Jin
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.